News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Mohammad Alhomoud: What would you do when you ran into 2 legendary mentors?
Photo from Mohammad Alhomoud/X
Dec 17, 2023, 16:13

Mohammad Alhomoud: What would you do when you ran into 2 legendary mentors?

Quoting Mohammad Alhomoud, bone marrow transplant fellow at the Memorial Sloan Kettering Cancer Center, on X/Twitter:

”What would you do when you ran into 2 legendary mentors? You take a picture.”

Source: Mohammad Alhomoud/X

Amer Zeidan ASH23 cancer legendary mentors Mentee Mohammad Alhomoud Navneet Majhail OncoDaily Oncology when you ran into 2 legendary mentors
Special Coverage
Radiotherapy
Apr 18, 2025, 15:25
Why Radiation Can Cause Hair Loss? Hair loss (Alopecia) and Radiotherapy
Blog
Apr 18, 2025, 15:15
Kevin Hall retires from the National Institutes of Health
Blog
Apr 18, 2025, 15:15
American Association for Cancer Research - How Will AI Impact the Future of Pathology?
Blog
Apr 18, 2025, 15:03
The Max Foundation - Thank you to everyone who attended 2025 Maximize Life Gala
Blog
Apr 18, 2025, 14:55
Sylvester Comprehensive Cancer Center is expanding access to world-class cancer care in Broward County
Oncolibrary
Apr 18, 2025, 14:48
New Paper Alert: Polygenic Risk Score Use Dramatically Improves Prostate Cancer Detection: Results from the BARCODE1 Study
Opinion
Apr 18, 2025, 14:42
Berta Marti Fuster: That’s a wrap on the 2025 Analog Devices' General Technical Conference
Blog
Apr 18, 2025, 14:29
Antonio Giordano: Rep. Jesse Topper visited Sbarro Health Research Organization Genetic Research Laboratory
Blog
Apr 18, 2025, 14:07
Humaid Al-Shamsi: BCI signed an MoU with the European Institute of Oncology at Abu Dhabi Global Health Week
Blog
Apr 18, 2025, 13:54
Tanja Obradovic: Novel cell therapy is entering clinical development space
Drugs
Apr 18, 2025, 13:39
Amol Akhade: First-line treatment options for NSCLC with uncommon EGFR mutations
Blog
Apr 18, 2025, 13:07
Tanja Obradovic: Even rougher times ahead for Biotech?